25 XP   0   0   10

Anatara Lifesciences Ltd
Buy, Hold or Sell?

Let's analyse Anatara Lifesciences Ltd together

PenkeI guess you are interested in Anatara Lifesciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Anatara Lifesciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Anatara Lifesciences Ltd

I send you an email if I find something interesting about Anatara Lifesciences Ltd.

Quick analysis of Anatara Lifesciences Ltd (30 sec.)










What can you expect buying and holding a share of Anatara Lifesciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.00
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-47.6%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.021 - A$0.026
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Anatara Lifesciences Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.02

Intrinsic Value Per Share

A$-0.06 - A$-0.05

Total Value Per Share

A$-0.06 - A$-0.04

2. Growth of Anatara Lifesciences Ltd (5 min.)




Is Anatara Lifesciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$604.5k$892.1k-$287.5k-47.6%

How much money is Anatara Lifesciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$1.6m$335k25.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Anatara Lifesciences Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#880 / 1050

Most Revenue
#890 / 1050

Most Profit
#269 / 1050

Most Efficient
#342 / 1050
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Anatara Lifesciences Ltd? (5 min.)

Welcome investor! Anatara Lifesciences Ltd's management wants to use your money to grow the business. In return you get a share of Anatara Lifesciences Ltd.

What can you expect buying and holding a share of Anatara Lifesciences Ltd?

First you should know what it really means to hold a share of Anatara Lifesciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of Anatara Lifesciences Ltd is A$0.022. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anatara Lifesciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anatara Lifesciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anatara Lifesciences Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-35.8%-0.01-35.8%-0.01-44.8%-0.01-45.3%-0.01-38.0%
Usd Book Value Change Per Share0.00-7.8%0.00-7.8%-0.01-43.7%-0.01-27.1%0.002.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-7.8%0.00-7.8%-0.01-43.7%-0.01-27.1%0.002.1%
Usd Price Per Share0.02-0.02-0.04-0.08-0.30-
Price to Earnings Ratio-2.32--2.32--3.65--8.08--55.45-
Price-to-Total Gains Ratio-10.69--10.69--3.74--2.17--25.23-
Price to Book Ratio5.08-5.08-6.77-6.71-10.62-
Price-to-Total Gains Ratio-10.69--10.69--3.74--2.17--25.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0143858
Number of shares69512
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (69512 shares)-119.06-414.92
Gains per Year (69512 shares)-476.23-1,659.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-476-4860-1660-1670
20-952-9620-3319-3330
30-1429-14380-4979-4990
40-1905-19140-6639-6650
50-2381-23900-8298-8310
60-2857-28660-9958-9970
70-3334-33420-11618-11630
80-3810-38180-13277-13290
90-4286-42940-14937-14950
100-4762-47700-16597-16610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.03.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%3.010.00.023.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%3.010.00.023.1%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Anatara Lifesciences Ltd

About Anatara Lifesciences Ltd

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Fundamental data was last updated by Penke on 2024-02-14 05:03:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Anatara Lifesciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Anatara Lifesciences Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anatara Lifesciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-55.7%+55.7%
5Y-55.7%10Y-5,787.4%+5,731.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--172.8%+172.8%
TTM--221.6%+221.6%
YOY--289.5%+289.5%
5Y-55.7%-489.6%+433.9%
10Y-5,787.4%-608.7%-5,178.7%
1.1.2. Return on Assets

Shows how efficient Anatara Lifesciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • -142.5% Return on Assets means that Anatara Lifesciences Ltd generated $-1.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anatara Lifesciences Ltd:

  • The MRQ is -142.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -142.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-142.5%TTM-142.5%0.0%
TTM-142.5%YOY-143.4%+0.9%
TTM-142.5%5Y-97.2%-45.4%
5Y-97.2%10Y-58.5%-38.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.5%-12.4%-130.1%
TTM-142.5%-12.1%-130.4%
YOY-143.4%-11.3%-132.1%
5Y-97.2%-13.7%-83.5%
10Y-58.5%-15.1%-43.4%
1.1.3. Return on Equity

Shows how efficient Anatara Lifesciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • -218.8% Return on Equity means Anatara Lifesciences Ltd generated $-2.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anatara Lifesciences Ltd:

  • The MRQ is -218.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -218.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-218.8%TTM-218.8%0.0%
TTM-218.8%YOY-185.9%-33.0%
TTM-218.8%5Y-126.6%-92.2%
5Y-126.6%10Y-73.9%-52.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-218.8%-15.8%-203.0%
TTM-218.8%-15.2%-203.6%
YOY-185.9%-14.2%-171.7%
5Y-126.6%-18.5%-108.1%
10Y-73.9%-19.7%-54.2%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Anatara Lifesciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Anatara Lifesciences Ltd is operating .

  • Measures how much profit Anatara Lifesciences Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anatara Lifesciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-117.2%+117.2%
5Y-117.2%10Y-5,919.6%+5,802.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--288.2%+288.2%
TTM--225.9%+225.9%
YOY--293.2%+293.2%
5Y-117.2%-482.8%+365.6%
10Y-5,919.6%-607.6%-5,312.0%
1.2.2. Operating Ratio

Measures how efficient Anatara Lifesciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anatara Lifesciences Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.606-1.606
5Y1.60610Y96.886-95.280
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.938-2.938
TTM-3.314-3.314
YOY-3.856-3.856
5Y1.6066.009-4.403
10Y96.8867.532+89.354
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Anatara Lifesciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Anatara Lifesciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.87 means the company has $2.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anatara Lifesciences Ltd:

  • The MRQ is 2.866. The company is able to pay all its short-term debts. +1
  • The TTM is 2.866. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.866TTM2.8660.000
TTM2.866YOY4.749-1.883
TTM2.8665Y7.875-5.009
5Y7.87510Y19.914-12.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8664.025-1.159
TTM2.8664.485-1.619
YOY4.7495.591-0.842
5Y7.8756.256+1.619
10Y19.9146.556+13.358
1.3.2. Quick Ratio

Measures if Anatara Lifesciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 2.94 means the company can pay off $2.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anatara Lifesciences Ltd:

  • The MRQ is 2.945. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.945. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.945TTM2.9450.000
TTM2.945YOY4.827-1.882
TTM2.9455Y9.670-6.725
5Y9.67010Y26.939-17.269
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9453.664-0.719
TTM2.9454.164-1.219
YOY4.8275.485-0.658
5Y9.6706.122+3.548
10Y26.9396.377+20.562
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Anatara Lifesciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Anatara Lifesciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anatara Lifesciences Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.35 means that Anatara Lifesciences Ltd assets are financed with 34.9% credit (debt) and the remaining percentage (100% - 34.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anatara Lifesciences Ltd:

  • The MRQ is 0.349. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.349. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.349TTM0.3490.000
TTM0.349YOY0.228+0.120
TTM0.3495Y0.182+0.167
5Y0.18210Y0.115+0.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3490.331+0.018
TTM0.3490.328+0.021
YOY0.2280.262-0.034
5Y0.1820.370-0.188
10Y0.1150.380-0.265
1.4.2. Debt to Equity Ratio

Measures if Anatara Lifesciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 53.5% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anatara Lifesciences Ltd:

  • The MRQ is 0.535. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.535. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.535TTM0.5350.000
TTM0.535YOY0.296+0.240
TTM0.5355Y0.242+0.293
5Y0.24210Y0.147+0.095
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5350.375+0.160
TTM0.5350.395+0.140
YOY0.2960.319-0.023
5Y0.2420.428-0.186
10Y0.1470.469-0.322
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Anatara Lifesciences Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anatara Lifesciences Ltd generates.

  • Above 15 is considered overpriced but always compare Anatara Lifesciences Ltd to the Biotechnology industry mean.
  • A PE ratio of -2.32 means the investor is paying $-2.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anatara Lifesciences Ltd:

  • The EOD is -1.826. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.324. Based on the earnings, the company is expensive. -2
  • The TTM is -2.324. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.826MRQ-2.324+0.498
MRQ-2.324TTM-2.3240.000
TTM-2.324YOY-3.647+1.323
TTM-2.3245Y-8.084+5.761
5Y-8.08410Y-55.451+47.366
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.826-2.500+0.674
MRQ-2.324-2.208-0.116
TTM-2.324-2.771+0.447
YOY-3.647-4.423+0.776
5Y-8.084-6.089-1.995
10Y-55.451-6.214-49.237
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anatara Lifesciences Ltd:

  • The EOD is -1.635. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.080. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.080. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.635MRQ-2.080+0.446
MRQ-2.080TTM-2.0800.000
TTM-2.080YOY-4.123+2.043
TTM-2.0805Y-2,106.052+2,103.971
5Y-2,106.05210Y-1,144.522-961.529
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.635-3.280+1.645
MRQ-2.080-2.833+0.753
TTM-2.080-3.523+1.443
YOY-4.123-6.018+1.895
5Y-2,106.052-8.184-2,097.868
10Y-1,144.522-8.594-1,135.928
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Anatara Lifesciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.08 means the investor is paying $5.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anatara Lifesciences Ltd:

  • The EOD is 3.995. Based on the equity, the company is fair priced.
  • The MRQ is 5.085. Based on the equity, the company is overpriced. -1
  • The TTM is 5.085. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.995MRQ5.085-1.090
MRQ5.085TTM5.0850.000
TTM5.085YOY6.768-1.684
TTM5.0855Y6.705-1.620
5Y6.70510Y10.624-3.919
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.9952.050+1.945
MRQ5.0851.842+3.243
TTM5.0852.099+2.986
YOY6.7683.053+3.715
5Y6.7053.544+3.161
10Y10.6243.828+6.796
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anatara Lifesciences Ltd.

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Anatara Lifesciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%-0.015+461%-0.009+249%0.001-465%
Book Value Per Share--0.0060.0060%0.008-32%0.018-69%0.037-85%
Current Ratio--2.8662.8660%4.749-40%7.875-64%19.914-86%
Debt To Asset Ratio--0.3490.3490%0.228+53%0.182+91%0.115+204%
Debt To Equity Ratio--0.5350.5350%0.296+81%0.242+121%0.147+264%
Dividend Per Share----0%-0%-0%-0%
Eps---0.012-0.0120%-0.015+25%-0.015+26%-0.013+6%
Free Cash Flow Per Share---0.013-0.0130%-0.013-1%-0.011-17%-0.011-19%
Free Cash Flow To Equity Per Share---0.005-0.0050%-0.013+194%0.001-659%0.007-169%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.202-17%
Intrinsic Value_10Y_max---0.049--------
Intrinsic Value_10Y_min---0.062--------
Intrinsic Value_1Y_max---0.010--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max---0.026--------
Intrinsic Value_3Y_min---0.030--------
Intrinsic Value_5Y_max---0.037--------
Intrinsic Value_5Y_min---0.044--------
Market Cap3693668.000-27%4701032.0004701032.0000%9234170.000-49%20919592.400-78%75854509.200-94%
Net Profit Margin----0%-0%-0.5570%-57.8740%
Operating Margin----0%-0%-1.1720%-59.1960%
Operating Ratio----0%-0%1.606-100%96.886-100%
Pb Ratio3.995-27%5.0855.0850%6.768-25%6.705-24%10.624-52%
Pe Ratio-1.826+21%-2.324-2.3240%-3.647+57%-8.084+248%-55.451+2286%
Price Per Share0.022-27%0.0280.0280%0.055-49%0.125-78%0.452-94%
Price To Free Cash Flow Ratio-1.635+21%-2.080-2.0800%-4.123+98%-2106.052+101131%-1144.522+54913%
Price To Total Gains Ratio-8.399+21%-10.690-10.6900%-3.745-65%-2.172-80%-25.234+136%
Quick Ratio--2.9452.9450%4.827-39%9.670-70%26.939-89%
Return On Assets---1.425-1.4250%-1.434+1%-0.972-32%-0.585-59%
Return On Equity---2.188-2.1880%-1.859-15%-1.266-42%-0.739-66%
Total Gains Per Share---0.003-0.0030%-0.015+461%-0.009+249%0.001-465%
Usd Book Value--604557.360604557.3600%892117.732-32%1947470.351-69%4033385.718-85%
Usd Book Value Change Per Share---0.002-0.0020%-0.010+461%-0.006+249%0.000-465%
Usd Book Value Per Share--0.0040.0040%0.005-32%0.012-69%0.024-85%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.008-0.0080%-0.010+25%-0.010+26%-0.008+6%
Usd Free Cash Flow---1477566.826-1477566.8260%-1464367.854-1%-1220643.761-17%-1194889.648-19%
Usd Free Cash Flow Per Share---0.009-0.0090%-0.009-1%-0.007-17%-0.007-19%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.009+194%0.001-659%0.004-169%
Usd Market Cap2415289.505-27%3074004.8253074004.8250%6038223.763-49%13679321.470-78%49601263.566-94%
Usd Price Per Share0.014-27%0.0180.0180%0.036-49%0.081-78%0.295-94%
Usd Profit---1322962.633-1322962.6330%-1658037.341+25%-1677094.079+27%-1404565.234+6%
Usd Revenue----0%-0%86760.106-100%233274.836-100%
Usd Total Gains Per Share---0.002-0.0020%-0.010+461%-0.006+249%0.000-465%
 EOD+3 -5MRQTTM+0 -0YOY+12 -175Y+10 -2110Y+7 -25

4.2. Fundamental Score

Let's check the fundamental score of Anatara Lifesciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.826
Price to Book Ratio (EOD)Between0-13.995
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.945
Current Ratio (MRQ)Greater than12.866
Debt to Asset Ratio (MRQ)Less than10.349
Debt to Equity Ratio (MRQ)Less than10.535
Return on Equity (MRQ)Greater than0.15-2.188
Return on Assets (MRQ)Greater than0.05-1.425
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Anatara Lifesciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.994
Ma 20Greater thanMa 500.023
Ma 50Greater thanMa 1000.023
Ma 100Greater thanMa 2000.026
OpenGreater thanClose0.022
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets1,419
Total Liabilities495
Total Stockholder Equity925
 As reported
Total Liabilities 495
Total Stockholder Equity+ 925
Total Assets = 1,419

Assets

Total Assets1,419
Total Current Assets1,416
Long-term Assets3
Total Current Assets
Cash And Cash Equivalents 351
Short-term Investments 50
Net Receivables 1,004
Other Current Assets 11
Total Current Assets  (as reported)1,416
Total Current Assets  (calculated)1,416
+/-0
Long-term Assets
Property Plant Equipment 3
Long-term Assets  (as reported)3
Long-term Assets  (calculated)3
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities494
Long-term Liabilities1
Total Stockholder Equity925
Total Current Liabilities
Accounts payable 79
Other Current Liabilities 415
Total Current Liabilities  (as reported)494
Total Current Liabilities  (calculated)494
+/-0
Long-term Liabilities
Other Liabilities 1
Long-term Liabilities  (as reported)1
Long-term Liabilities  (calculated)1
+/-0
Total Stockholder Equity
Common Stock21,369
Retained Earnings -20,792
Accumulated Other Comprehensive Income 348
Total Stockholder Equity (as reported)925
Total Stockholder Equity (calculated)925
+/-0
Other
Capital Stock21,369
Cash and Short Term Investments 401
Common Stock Shares Outstanding 73,429
Liabilities and Stockholders Equity 1,419
Net Debt -351
Net Invested Capital 925
Net Tangible Assets 925
Net Working Capital 922
Property Plant and Equipment Gross 3



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-30
> Total Assets 
4
50
72
7,454
5,628
13,920
12,317
9,812
6,382
3,344
4,327
1,768
1,419
1,4191,7684,3273,3446,3829,81212,31713,9205,6287,45472504
   > Total Current Assets 
0
0
0
7,454
5,603
13,904
12,276
9,769
6,355
3,336
4,242
1,701
1,416
1,4161,7014,2423,3366,3559,76912,27613,9045,6037,454000
       Cash And Cash Equivalents 
3
43
66
7,450
1,498
6,387
8,767
1,448
1,360
2,682
3,432
1,120
351
3511,1203,4322,6821,3601,4488,7676,3871,4987,45066433
       Short-term Investments 
0
0
0
0
4,053
7,438
2,093
6,294
4,050
0
50
50
50
50505004,0506,2942,0937,4384,0530000
       Net Receivables 
1
2
0
0
52
60
1,332
1,946
896
630
773
509
1,004
1,0045097736308961,9461,33260520021
       Other Current Assets 
0
6
6
3
0
19
84
82
49
24
37
22
11
112237244982841903660
   > Long-term Assets 
0
0
0
0
25
16
41
43
27
7
85
67
3
36785727434116250000
       Property Plant Equipment 
0
0
0
0
25
16
41
43
20
7
85
67
3
36785720434116250000
       Intangible Assets 
0
0
0
0
0
0
0
7
7
0
0
0
0
0000770000000
> Total Liabilities 
20
146
353
228
147
445
295
1,225
467
487
497
403
495
4954034974874671,22529544514722835314620
   > Total Current Liabilities 
20
146
353
228
147
445
295
608
453
464
403
358
494
49435840346445360829544514722835314620
       Short-term Debt 
0
0
0
0
4,053
7,438
2,093
6,294
4,050
14
14
21
0
02114144,0506,2942,0937,4384,0530000
       Accounts payable 
0
0
7
228
119
403
45
81
117
34
196
153
79
79153196341178145403119228700
       Other Current Liabilities 
0
0
0
0
28
41
251
481
336
430
207
206
415
41520620743033648125141280000
   > Long-term Liabilities 
0
0
0
0
0
0
0
617
14
23
94
45
1
1459423146170000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
66
45
0
045660000000000
       Other Liabilities 
0
0
0
0
0
0
0
639
14
23
28
0
1
102823146390000000
> Total Stockholder Equity
0
0
0
7,226
5,481
13,475
12,021
8,587
5,916
2,857
3,830
1,364
925
9251,3643,8302,8575,9168,58712,02113,4755,4817,226000
   Retained Earnings -20,792-18,984-16,604-14,736-11,525-8,938-5,369-3,664-2,940-1,265000
   Accumulated Other Comprehensive Income 
0
0
0
0
25
198
448
584
499
553
678
439
348
348439678553499584448198250000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-3,285
Operating Income-2,021-3,285
 
Operating Expense (+$)
Research Development1,602
Selling General Administrative891
Selling And Marketing Expenses0
Operating Expense3,2852,494
 
Net Interest Income (+$)
Interest Income18
Interest Expense-2
Other Finance Cost-0
Net Interest Income16
 
Pretax Income (+$)
Operating Income-2,021
Net Interest Income16
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,023-3,267
EBIT - interestExpense = -2,023
-775
-2,021
Interest Expense2
Earnings Before Interest and Taxes (EBIT)-2,021-2,021
Earnings Before Interest and Taxes (EBITDA)-1,996
 
After tax Income (+$)
Income Before Tax-2,023
Tax Provision-0
Net Income From Continuing Ops-2,023-2,023
Net Income-2,023
Net Income Applicable To Common Shares-2,023
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,285
Total Other Income/Expenses Net1,246-16
 

Technical Analysis of Anatara Lifesciences Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anatara Lifesciences Ltd. The general trend of Anatara Lifesciences Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anatara Lifesciences Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anatara Lifesciences Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.024 < 0.024 < 0.026.

The bearish price targets are: 0.022 > 0.022 > 0.021.

Tweet this
Anatara Lifesciences Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anatara Lifesciences Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anatara Lifesciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anatara Lifesciences Ltd. The current macd is -0.0003633.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Anatara Lifesciences Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Anatara Lifesciences Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Anatara Lifesciences Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Anatara Lifesciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAnatara Lifesciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anatara Lifesciences Ltd. The current adx is 19.73.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Anatara Lifesciences Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Anatara Lifesciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anatara Lifesciences Ltd. The current sar is 0.0258416.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Anatara Lifesciences Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anatara Lifesciences Ltd. The current rsi is 39.99. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Anatara Lifesciences Ltd Daily Relative Strength Index (RSI) ChartAnatara Lifesciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anatara Lifesciences Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Anatara Lifesciences Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Anatara Lifesciences Ltd Daily Stochastic Oscillator ChartAnatara Lifesciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anatara Lifesciences Ltd. The current cci is -66.06606607.

Anatara Lifesciences Ltd Daily Commodity Channel Index (CCI) ChartAnatara Lifesciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anatara Lifesciences Ltd. The current cmo is -33.11911936.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Anatara Lifesciences Ltd Daily Chande Momentum Oscillator (CMO) ChartAnatara Lifesciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anatara Lifesciences Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Anatara Lifesciences Ltd Daily Williams %R ChartAnatara Lifesciences Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Anatara Lifesciences Ltd.

Anatara Lifesciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anatara Lifesciences Ltd. The current atr is 0.00041988.

Anatara Lifesciences Ltd Daily Average True Range (ATR) ChartAnatara Lifesciences Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anatara Lifesciences Ltd. The current obv is -36,056,404.

Anatara Lifesciences Ltd Daily On-Balance Volume (OBV) ChartAnatara Lifesciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anatara Lifesciences Ltd. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Anatara Lifesciences Ltd Daily Money Flow Index (MFI) ChartAnatara Lifesciences Ltd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anatara Lifesciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-06STOCH